RNA G-四重复RIBOTAC介导的 lncRNA TERRA 的目标降解
Elias Khaskia1, Dipak Dahatonde1, Raphael I Benhamou1
1The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112002, Israel.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 6, 2025
概括
新的RIBOTAC技术针对TERRA (端粒重复含有RNA) 来降解在癌细胞中. 这种方法表明,通过准RNA调节,开发新型癌症疗法具有前途.
科学领域:
- 分子生物学分子生物学
- 在RNA生物学,RNA生物学.
- 癌症研究 癌症研究
背景情况:
- 长非编码RNAs (lncRNAs) 调节基因表达,并与癌症有关.
- TERRA (端粒重复含有RNA) 是一个对端粒维护和基因组稳定性至关重要的 lncRNA.
- TERRA失调与端粒功能障碍和替代端粒延长 (ALT) 癌症有关.
研究的目的:
- 使用RIBOTAC技术开发针对TERRA的新型小分子.
- 研究这些化合物对TERRA的选择性降解.
- 评估TERRA降解对癌细胞表型的影响.
主要方法:
- 开发一流的RIBOTAC,针对TERRA的G-四重复 (G4) 结构.
- 选择性TERRA绑定和RNase L招聘的评估.
- 在HeLa和U2OS (ALT癌症模型) 细胞中评估TERRA-RIBOTACs.
主要成果:
- RIBOTACs选择性地结合TERRA G4s并招募RNase L进行降解.
- 在特定位置 (7p, 13q, 15q, 20q) 观察到TERRA降解.
- TERRA降解损害了端粒功能,并减少了癌细胞中的殖民地形成.
结论:
- RIBOTAC技术提供了一种针对像TERRA这样的lncRNA的新策略.
- 选择性TERRA降解对端粒维持和癌细胞增殖有功能性的影响.
- 对TERRA的化学操纵为基于RNA的癌症药物开发开辟了新的途径.
更多相关视频
09:13Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
7.8K
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.1K
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs
3.5K
3.5K
Riboswitches
9.5K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.5K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
